Get started
AMGEN 12/29AMGEN 12/29AMGEN 12/29

AMGEN 12/29

No trades
See on Supercharts
Overview
Analysis News

AMGC chart


Full chart

Key terms


Outstanding amount
‪700.00 M‬ GBP
Face value
1,000.00 GBP
Minimum denomination
100,000.00 GBP
Coupon
4.00% (Fixed)
Coupon frequency
Annual
Yield to maturity
4.96%
Maturity date
Sep 13, 2029
Term to maturity
4 years

About AMGEN 12/29


Issuer
Amgen, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
amgen.com
Issue date
Sep 13, 2012
ISIN
XS0829324457
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGC analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

AMGC news